Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
The latest update is out from Impedimed Limited ( (AU:IPD) ).
ImpediMed Limited has announced a change in the director’s interest notice involving Ms. Christine Emmanuel-Donnelly. The change involves a transfer of shares between entities associated with Ms. Emmanuel-Donnelly, specifically the Donnelly Superannuation Fund and IDEAHL Pty Ltd. This adjustment does not involve any monetary consideration and reflects a redistribution of shares, maintaining the overall stake in the company.
More about Impedimed Limited
ImpediMed Limited operates in the medical technology industry, focusing on bioimpedance spectroscopy devices. These devices are primarily used for assessing and managing fluid status and body composition, catering to healthcare providers and patients globally.
YTD Price Performance: -50.0%
Average Trading Volume: 33,255
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $66.54M
Find detailed analytics on IPD stock on TipRanks’ Stock Analysis page.
